Compare iShares MSCI Australia ETF (EWA) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Australia ETF vs Intuitive Surgical, Inc. — how do they compare? iShares MSCI Australia ETF trades at $28.27 (market cap $1.17B), while Intuitive Surgical, Inc. trades at $418 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 125.4× iShares MSCI Australia ETF's market cap, and iShares MSCI Australia ETF is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Australia ETF for 63 Days and Intuitive Surgical, Inc. for 84 Days on average.
| EWA | ISRG | |
|---|---|---|
Market Cap | $1.17B | $146.76B |
Volume | 2,121,231 | 2,529,814 |
Sector | Broad Market / Factor | Health |
52-Week High | $30.43 | $592.85 |
52-Week Low | $24.95 | $332.02 |
Typical Hold Time | 63 Days | 84 Days |
Enterprise Value | — | $141.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWA, the iShares MSCI Australia ETF, trades at $28.23, down 1.12% amid broader Australian market weakness. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. Recent institutional activity includes Squarepoint Ops reducing its stake by 91.2% while other firms like Empowered Funds and Cetera Investment Advisers increased positions. The ETF serves as a commodity proxy, benefiting from Australia's export-driven economy.
The outlook remains cautious with technical weakness and mixed institutional sentiment. Upside potential exists if commodity demand drives Australian equities higher, but near-term risks include persistent inflation concerns and tight monetary policy. The Seeking Alpha buy rating targeting $34.83 suggests over 20% upside potential from current levels.
Intuitive Surgical (ISRG) trades at $414.52, up 2.41% with strong bullish technical signals and consistent earnings beats. The company demonstrates robust fundamentals with 2025 revenue reaching $10.06 billion and net income of $2.86 billion, maintaining impressive profit margins above 28%. Recent expansion into ambulatory surgery centers and international markets like India and Japan provides growth catalysts, though China headwinds present challenges. Technical indicators show bullish momentum with support at $411 and resistance at $417.
ISRG presents a compelling growth story with dominant market positioning in robotic surgery and strong recurring revenue streams. The stock offers 16% upside to the consensus price target of $480.78, supported by 70% analyst buy ratings. Key risks include competitive pressures in robotic surgery and international market volatility. The company's consistent earnings outperformance and expanding global footprint suggest continued growth potential despite near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Australia ETF
EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
